Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LOL, I guess charts do lie, because it also has a june 13th, 2013 price of over 55c, yet I believe it's only June 5 today! For April 17th it says the high was 54c low 46c. The finger has to be on the lines in the chart, not above them or else it gets wacky.
Every 3-6 months something comes out saying how the Pres is going to work on it, and people come out of the woodwork saying they are worried that the sky is falling on IP stocks. WDDD doesn't own patents about rounded edges, this isn't some frivolous lawsuit company, it only takes a few minutes of DD to see that.IMO
Now go ahead and look through the filings since then, there is not one form 4 from him selling any shares in recent years, he let his options expire and did not convert them when he could easily have made a bundle off those shares. Those shares were part of his 2007 5 year employment agreement, meaning he took no shares for those 5 years.
So let me get this straight, Mr. Kidrin let his 15MM options expire worthless and he has had the authority to do a R/S since 2010 and hasn't, WOW, sounds like a shareholders dream CEO to me!
Since the announcement of the vote for the R/S shorters have moved in. Most stocks go down on anything having to do with R/S so shorters jump in. In this case, management already has the authority to enact a R/S, since June 2010, they are just looking to extend that authority, (as it expires at the next annual meeting), so when the time is right they can take the stock onto a higher exchange where institutions can buy as stated in the PR:
"We have been considering moving to a senior market exchange pending a successful Markman hearing and litigation," stated Thom Kidrin, Worlds CEO. "We have authorization for a reverse split from a prior proxy and want to maintain it in the new proxy so that we have the option to move to a senior exchange in the event of a successful outcome to the pending patent infringement lawsuit. Uplisting typically exposes the stock to a broader range of investors and funds, which ultimately may benefit our entire shareholder community."
IMO, it was bad timing to ask for it right before the markman, I think the real reason for the annual shareholder meeting is to raise the A/S as they are maxed out when fully diluted, but since WDDD doesn't do annual shareholder meetings very often, last one was 2010, and they are costly, they put everything into this one. Mr. Kidrin explicitly states in the PR that the R/S wouldn't be until after a successful markman and litigation and would be used to get onto a higher exchange, which is all good news for shareholders.
Right now this very second management already has the approval to do a R/S, and they haven't, they could have for the past couple of years but haven't. Fully diluted the shares come to about 100MM shares, which leaves no room if any deals for other patent portfolios come up. After a successful markman win it would be beneficial to all to get onto a higher exchange such as NASDAQ or AMEX where big financial institutions would be allowed to buy the stock, in that case a small reverse split would be very beneficial to all. You either trust in management to do the right thing or you don't, obviously they have the right to do a R/S right now and have used discretion in that authority, and now they are just asking to continue to have that option.
If Both Approved and enacted. Best case scenario Current shares make up 33% of WDDD authorized shares. <# of shares drop to 50 million and then 100 million new shares are authorized>
Worst case scenario current shares will be valued at 5% of authorized shares. <# of shares are dropped to 5 million then 145 million shares are authorized>
I just do not see how giving up 66% to 95% of current patent (possible value of billion plus) would be beneficial to current shareholders. Please feel free to school me because I would love to get other investors thoughts.
Your points and conclusion do not correlate. The percentage of O/S to A/S is not what's being given up, that makes no sense whatsoever. The O/S may not go up at all even though the A/S are raised, so nothing is lost. A R/S also does not change your percentage of ownership at all. You are assuming that all the possible available shares will be diluted to the A/S number. To use your number of a billion $$$ plus for the patents, if the A/S where raised to 150MM yet the O/S went unchanged at around 100MM, that would give the stock a rough price of $10 per share. If a R/S of 2:1 occured to get onto a higher exchange and bring in the big boys, the O/S would go down to 50MM, causing the stock to reach a $20 share price, both cases, you have lost no value. The value of your stock only goes down when dilution occurs without any added value, not when the A/S get raised. To be clear, authorized shares are just that, shares authorized to be used by the company, but they are not shares outstanding. Once again, you either trust in management to do the right thing or you don't.
I will say todays PR covered all the bases. It tells everyone that he could have done a R/S this whole time, even right now today, but didn't, and exactly when and why he would do it in the future if need be. I'm with you that I like how he worded it, stating after a successful markman and litigation, making sure to let us know he wouldn't do it before it's best possible timing. I guess if the CEO was a slimeball he would have done the R/S already, but instead he put up his own option shares to cover the possible shares needed for the recent financing, putting his own money where his mouth is!
Lookie what I found! Back in 2010 WDDD had an annual shareholders meeting, and guess what, a R/S was on the ballot, word for word the same way. It got approved back then but the company never did it.
That's false info, the debs can be converted at 85% of the market price, which equals a 15% discount, not much at all. If you read the 14A you would see that those shares are already being held in an account and covered by the CEO's own options if need be.
Cooler, unfortunately the 14A for WDDD never mentions the R/S being for an uplist, as opposed to this other example linked below, that specifically mentions a R/S being for an uplist.
The proposed Reverse Stock Split is to provide us with sufficient flexibility to take advantage of corporate opportunities and/or financings should the opportunities arise. Without the Reverse Stock Split, we would not have sufficient number of authorized Common Shares to engage in these types of transactions and if we were to merely increase the number of our authorized Common Shares (as per Proposal no. 2), management is concerned that the number of our issued and outstanding Common Shares following any such transaction might be excessive, given our current financial condition
.
WDDD management just needs to give it some time, let's see a markman win first, let's see a damages report from the lawyers first so the market can better understand what these patents are worth, let's see more lawsuits announced, let's wait a little longer for a settlement, the price of the stock will take care of itself. There are other IP stocks that have a very similar share structure and they are doing just fine. WDDD management just needs the authorized share count raised, not a R/S.
Timing. Let's first see what this baby can do! Let's see what a markman win looks like to the share price. Let's see how it looks after the lawyers release the damages report and the market can get a better idea what these patents are really worth. Give some more time for a possible settlement to come in. Then if they really need it to uplist do a small 1:2 split.
A R/S does not change the authorized shares, only outstanding shares. I suggest everyone vote for the raise in authorized shares but vote no to the R/S.
LivingSocial, a daily deals website, has trailed Groupon since it launched. But this is an industry in which trailing the leading company is a very bad sign. As the financial troubles of Groupon demonstrate, the online daily deal industry started to fall apart not long after it began. Groupon’s share price, which reached a high of more than $26 after its initial public offering, was trading as low as $2.60 last year. While the stock is up on improved sales, the company remains unprofitable.
The situation is even worse for LivingSocial. Leading advertising publication AdWeek recently reported that sources would not be surprised if the company “was sold to a larger company or liquidated piece by piece by spring 2014.” That is a long way from when Amazon.com confidently invested $175 million in LivingSocial in 2010. The deal soured as the huge e-commerce company wrote down the investment by $169 million in late 2012. More recently, an Amazon SEC filing indicated that LivingSocial lost $50 million in the first quarter of this year, compared to a profit of $156 million in the same period a year ago.
The biggest competitors to both LivingSocial and Groupon are eBay, American Express and Amazon’s own AmazonLocal service. Each has a huge customer base and significant amounts of data about its customers, which they can use to target deals. LivingSocial does not stand a chance.
I read it too, and yes it doesn't make sense. It's clear they don't have majority vote, insiders control about 10MM shares of a 84MM share O/S, so I can't see it passing at all, no one in their right mind would vote for that. Plus many other patent plays have similar share structures and they are doing just fine. Part of the deal of the last financing was warrants that could be converted at 50c, which would bring in another $2MM+, so the need for more cash is pretty much covered unless they want to acquire patent portfolios like Vringo did. A R/S would mean they wouldn't need to raise the authorized, so the only reason I could see puttting that in there is to get people to vote for the raise in authorized shares, almost like forcing people to choose the lesser of two evils. I have no problem with the raise in authorized shares because public companies use shares for a variety of reasons and they are currently maxed out right now if everything was converted, plus if they acquired some more patent portfolios that would be great. Maybe like I wrote, if they had only asked for a raise in the authorized many would have said no, but by throwing in the possible R/S scenario people will be more likely to ok the raise. Either way, nothing will happen until July 15th. I think what would really help the stock is a damages report as that would give everyone some concrete guidance as to what the stock is worth.
No, because time is running out. What happened a month ago doesn't indicate what will happen now, there are many factors that have changed since then, one being that we are a month away from the markman hearing and the stock is still undervalued. If the stock were sitting at $1 that would be a different story. Lots and lots of accumulation has taken place in the 40s and the stock is poised for a breakout.
No one knows for sure how the runs will go, NO ONE!!! There are so many possibilities. Let's just say for whatever reason the stock is still around 50c at the markman hearing, I don't believe you will see a sell off of magnitude, because the risk reward at that price is tremendous. A markman win would take the stock straight up to $1.50-$2, up 200%-300%, whereas if the stock runs to $1 pre-markman, some will likely sell because a markman win would get them 50%-100%, which for some isn't worth the risk.
Most likely Max already has the info, it just hasn't been released to the public yet. What EDVA is trying to do is make sense of what is out there for the layman, to put it all in one place and explain things in a more simplified manner so everyone can understand better what WDDD is all about.IMO
Good lawyers are always trying to get a settlement, no matter how good your case is, you never know what a jury will come up with, LOL, a great example would be the jury calculator mistake in the Vringo case.
Activision has a history of settling their cases, whereas Google has made it very clear they will fight tooth and nail with patent trolls. We need the positive markman hearing first.
Unfortunately everytime you convince someone at WDDD into SCRC it hurts WDDD. What happened to the 20 posts per day at WDDD? Where's our cheerleader??? Having a great day there and no cheerleader to get everyone riled up!!!
We are using a patented material to develop our rapid dissolve products. This patented material comprises a majority of our formula and is patented by its manufacturer. We do not have exclusive use for this patented material for our rapid dissolve products. The remainder of our formulation to develop these potential rapid dissolve products, such as particle size, coating agents, flavors, binders, manufacturing lubricants, package design, manufacturing process, packaging materials and packaging process, are treated as our trade secrets. Although any competitor or potential competitor may use the same patented material to make a rapidly dissolving product, we rely on the trade secret aspect for our competitive edge in the market for rapid dissolve products.
Competitors
Large, vertically integrated industry players engaged in the development, manufacture, marketing, sale and distribution of generic and/or branded specialty pharmaceuticals in various therapeutic categories include Actavis Group, Apotex, Dr. Reddy’s, Glenmark Pharmaceuticals, Jubilant Life Sciences, Mylan, Par Pharmaceutical Companies, Ranbaxy Laboratories, Sandoz (a division of Novartis), Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Barr Laboratories (a division of Teva), and Watson Pharmaceuticals.
The group of small and middle market companies within which we compete for market share consists of Adams Laboratories, Blu Pharmaceuticals, Boca Pharmacal, Caraco, Hi-Tech Pharmacal, Impax Laboratories, Lanett Company, Missionpharma, Pharmaceutical Laboratories, Purepac Pharmaceutical, Qualitest Pharmaceuticals, and URL Pharma.
It costs lots and lots of money to bring a new product to market and do proper advertising. I don't think the time to get in is now, as now is when major money will be needed to get the ball rolling. Of course that doesn't mean the stock price can't go up, market caps and financials aren't always in alignment. Good luck!!!
Never said it would amount to dilution to the O/S, they were in better hands when they were in the CTO's possession, now they will be hitting the float, and at 3c a pop, 20,000,000 shares hitting the float will hurt BCYP share price.
Be careful here BCYP, they just issued 20,000,000 shares for 3c each! That's probably what's hitting the float now. Plus all the other options, warrants, ect.
On April 29, 2013, Blue Calypso, Inc. (the “Company”) entered into a series of agreements with the holder (the “Holder”) of its 8% Senior Secured Convertible Debentures (the “Debentures”). The Debentures were due on November 30, 2012. As of April 29, 2013, the aggregate amount outstanding under the Debentures, including all accrued and unpaid interest and fees, was $600,000. Pursuant to Amendment No. 1 to 8% Senior Secured Convertible Debentures (“Amendment No. 1 to 8% Debentures”), the conversion price of the Debentures was amended such that the aggregate amount outstanding under the Debentures will be convertible into an aggregate of 20,000,000 shares of the Company’s common stock (the “Conversion Shares”).
b) Conversion Price . The conversion price in effect on any Conversion Date shall be equal to $0.03 per share , subject to adjustment herein (the “ Conversion Price ”).
I don't remember if I already posted this but when I talked to the WDDD CEO a couple of months ago he said that in the past he was in talks to merge with Activision but it didn't work out, my guess is that is why the willful infringment claim will be easier to prove.
Oh, okay, my bad, must have just been a random coincidence that there was major support on the chart multiple times in the 38c-40c area. No, there aren't many posting TA here, but you can see that the stock is following TA, 48-50c was the high from the past 10 years, and that's been the area of major resistance, and 38-40c has been major support.
His prediction of the last pullback was on the chart, any novice chartist would have told you 1 of 2 things, either a pullback to the support at 38-40c or a full blown breakout after the resistance in 48-50c area. His pullback theory was based on the idea that the stock was moving because EDVA was coming out with the prior art article and that it wouldn't be justified. I personally don't believe it would have pulled back so far if it wasn't for EDVA releasing another pick which caused some to sell and chase the new play, which btw is down bigtime since it was announced because of major dilution.
News 
Market Data 
Discover 
AI
